MTOR and pancreatic neuroendocrine tumor: The third relevant cluster of commonly mutated genes are alterations in genes belonging to the mTOR pathway, which are mutated in about 15% of the pancreatic NET [29, 42], mostly affecting PTEN, TSC1, and TSC2 [42].